Clearside Biomedical Inc (CLSD) — Strategic Asset Allocation Index
Clearside Biomedical Inc (CLSD) has a Strategic Asset Allocation Index of 38.6% as of March 2023. Strategic assets (PP&E of $1.04 Million plus long-term investments of $-) total $1.04 Million, measured against net assets of $2.70 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Clearside Biomedical Inc Strategic Asset Allocation Index (2016–2022)
This chart shows how Clearside Biomedical Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of March 2023, the index stands at 38.6%, representing strategic assets of $1.04 Million against net assets of $2.70 Million USD. Explore CLSD cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Clearside Biomedical Inc (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Clearside Biomedical Inc from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Clearside Biomedical Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 7.1% | $755.00K | $755.00K | $- | $10.61 Million | ▲ +6.5 pp |
| 2021 | 0.6% | $238.00K | $238.00K | $- | $37.98 Million | ▼ -10.1 pp |
| 2020 | 10.8% | $944.00K | $944.00K | $- | $8.76 Million | ▲ +0.0 pp |
| 2019 | 10.7% | $1.20 Million | $1.20 Million | $- | $11.16 Million | ▲ +7.4 pp |
| 2018 | 3.3% | $790.00K | $790.00K | $- | $23.62 Million | ▼ -0.8 pp |
| 2017 | 4.1% | $885.00K | $885.00K | $- | $21.41 Million | ▲ +4.0 pp |
| 2016 | 0.1% | $94.00K | $94.00K | $- | $71.66 Million | — |